Literature DB >> 10205154

Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5' and first intron promoter regions.

C P Mack1, G K Owens.   

Abstract

The aims of the present studies were to define sufficient promoter sequences required to drive endogenous expression of smooth muscle (SM) alpha-actin and to determine whether regulation of SM alpha-actin expression in vivo is dependent on CArG (CC(A/T)6GG) cis elements. Promoter deletions and site directed mutagenesis techniques were used to study gene regulation in transgenic mice as well as in smooth muscle cell (SMC) cultures. Results demonstrated that a Lac Z transgene that contained 547 bp of the 5' rat SM alpha-actin promoter was sufficient to drive embryonic expression of SM alpha-actin in the heart and in skeletal muscle but not in SMCs. Transient transfections into SMC cultures demonstrated that the conserved CArG element in the first intron had significant positive activity, and gel shift analyses demonstrated that the intronic CArG bound serum response factor. A transgene construct from -2600 through the first intron (p2600Int/Lac Z) was expressed in embryos and adults in a pattern that closely mimicked endogenous SM alpha-actin expression. Expression in adult mice was completely restricted to SMCs and was detected in esophagus, stomach, intestine, lung, and nearly all blood vessels, including coronary, mesenteric, and renal vascular beds. Mutation of CArG B completely inhibited expression in all cell types, whereas mutation of the intronic CArG selectively abolished expression in SMCs, which suggests that it may act as an SMC-specific enhancer-like element. Taken together, these results provide the first in vivo evidence for the importance of multiple CArG cis elements in the regulation of SM alpha-actin expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10205154     DOI: 10.1161/01.res.84.7.852

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  69 in total

1.  Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury.

Authors:  C P Regan; P J Adam; C S Madsen; G K Owens
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Smooth muscle cell phenotypic switching in atherosclerosis.

Authors:  Delphine Gomez; Gary K Owens
Journal:  Cardiovasc Res       Date:  2012-03-08       Impact factor: 10.787

3.  Characterization of bacterial artificial chromosome transgenic mice expressing mCherry fluorescent protein substituted for the murine smooth muscle alpha-actin gene.

Authors:  John J Armstrong; Irina V Larina; Mary E Dickinson; Warren E Zimmer; Karen K Hirschi
Journal:  Genesis       Date:  2010-07       Impact factor: 2.487

4.  5' CArG degeneracy in smooth muscle alpha-actin is required for injury-induced gene suppression in vivo.

Authors:  Jennifer A Hendrix; Brian R Wamhoff; Oliver G McDonald; Sanjay Sinha; Tadashi Yoshida; Gary K Owens
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

5.  Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation.

Authors:  Julia A Halterman; H Moo Kwon; Ramin Zargham; Pamela D Schoppee Bortz; Brian R Wamhoff
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-07-14       Impact factor: 8.311

6.  Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.

Authors:  Kevin L Du; Hon S Ip; Jian Li; Mary Chen; Frederic Dandre; William Yu; Min Min Lu; Gary K Owens; Michael S Parmacek
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  Prostaglandin E2 inhibits α-smooth muscle actin transcription during myofibroblast differentiation via distinct mechanisms of modulation of serum response factor and myocardin-related transcription factor-A.

Authors:  Loka R K Penke; Steven K Huang; Eric S White; Marc Peters-Golden
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

8.  HRC is a direct transcriptional target of MEF2 during cardiac, skeletal, and arterial smooth muscle development in vivo.

Authors:  Joshua P Anderson; Evdokia Dodou; Analeah B Heidt; Sarah J De Val; Eric J Jaehnig; Stephanie B Greene; Eric N Olson; Brian L Black
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Whole animal knockout of smooth muscle alpha-actin does not alter excisional wound healing or the fibroblast-to-myofibroblast transition.

Authors:  James J Tomasek; Carol J Haaksma; Robert J Schwartz; Eric W Howard
Journal:  Wound Repair Regen       Date:  2012-12-18       Impact factor: 3.617

10.  PKA-dependent phosphorylation of serum response factor inhibits smooth muscle-specific gene expression.

Authors:  Alicia L Blaker; Joan M Taylor; Christopher P Mack
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-09-24       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.